Gasmotin

Gasmotin

mosapride

Manufacturer:

Sumitomo Dainippon

Distributor:

Zuellig
/
HI-Eisai

Marketer:

Eisai
Concise Prescribing Info
Contents
Mosapride citrate
Indications/Uses
GI symptoms associated w/ functional dyspepsia & chronic gastritis (heartburn, nausea, vomiting).
Dosage/Direction for Use
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Patients w/ GI hemorrhage, mechanical obstruction or perforation.
Special Precautions
Should not be taken for >2 wk if no clinically therapeutic outcome is observed. Monitor & observe patient for any abnormality. Discontinue if malaise, anorexia, thick urine & conjunctive bulbi coloring yellow occurs. Pregnancy & lactation. Childn. Elderly.
Adverse Reactions
Diarrhea/loose stools, dry mouth, malaise, eosinophilia, increased triglycerides, AST (GOT), ALT (GPT), ALP, γ-GTP & bilirubin; fulminant hepatitis, hepatic dysfunction, jaundice, edema, leukopenia, abdominal pain, nausea, vomiting, taste abnormality, palpitation, dizziness, light-headedness, headache.
Drug Interactions
Anticholinergic agents eg, atropine sulfate & butyl-scopolamine Br.
MIMS Class
GIT Regulators, Antiflatulents & Anti-Inflammatories
ATC Classification
A03FA09 - mosapride ; Belongs to the class of propulsives. Used in the treatment of functional gastrointestinal disorders.
Presentation/Packing
Form
Gasmotin FC tab 5 mg
Packing/Price
30's (P32/film-coated tab)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in